產品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時服務熱線
產品概述
名稱 | T-47D (人乳腺管癌細胞) (STR鑒定正確) |
別稱 | T-47-D; T47-D; T47D:A; T47D |
種屬 | 人 |
生長特性 | 貼壁細胞 |
細胞形態(tài) | 上皮細胞樣 |
凍存條件 | 凍存液:55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認) |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
背景描述 | T-47細胞分離自一位54歲乳房侵入性導管癌的女性患者胸水;發(fā)現(xiàn)分化的上皮亞株(T-47D)有細胞質連接和17-β-雌二醇及其他類固醇降血鈣素的受體,T-47D細胞表達WNT7B癌基因。 |
年齡(性別) | 女性;54歲 |
組織來源 | 乳腺;乳房;導管;來自導管癌肋膜滲出液轉移灶 |
細胞類型 | 腫瘤細胞 |
腫瘤類型 | 乳腺癌細胞 |
生物安全等級 | BSL-1 |
倍增時間 | ~36-46 hours |
致瘤性 | Yes, forms colonies in soft agar. |
受體表達情況 | calcitonin, expressed; androgen receptor, expressed; estrogen receptor, expressed; progesterone receptor, expressed; glucocorticoid receptor, positive, expressed; prolactin, expressed; calcitonin; androgen receptor, positive; progesterone receptor, p |
保藏機構 | ATCC; HTB-133 DSMZ; ACC-739 ECACC; 85102201 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 11,13 D2S1338 24 D3S1358 15,17 D5S818 12 D7S820 11 D8S1179 13 D13S317 12 D16S539 10 D18S51 17 D19S433 14 D21S11 28,31 FGA 23 PentaD 10,11,12 PentaE 7,14 TH01 6 TPOX 11 vWA 14 D6S1043 19 D12S391 19 D2S441 14 -
STR鑒定圖
參考文獻
-
Novel Self-Assembled Multifunctional Nanoprobes for Second-Near-Infrared-Fluorescence-Image-Guided Breast Cancer Surgery and Enhanced Radiotherapy Efficacy(2023/01/31)
作者:Yongqu Zhang, Wanling Liu, Xiangjie Luo
期刊:Advanced Science
影響因子 :15.100
-
Chiral Supramolecular Nanofibers Regulated Tumor-Derived Exosomes Secretion for Constructing an Anti-Tumor Extracellular Microenvironment(2024/02/29)
作者:Beibei Wu, Xiaoqiu Dou, Yu Zhao
期刊:Small
影響因子 :13.300
引用產品:CL-0228
-
Development of a rare earth nanoprobe enables in vivo real-time detection of sentinel lymph node metastasis of breast cancer using NIR-IIb imaging(2023/08/04)
作者:Yuanyuan Zhu, Liang Song, Yongqu Zhang
期刊:CANCER RESEARCH
DOI:10.1158/0008-5472.CAN-22-3432
影響因子 :11.200
引用產品:CL-0007 CL-0040 CL-0041 CL-0149 CL-0211 CL-0228 CL-0525
-
PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis(2023/06/01)
作者:Zhe Wang, Ruolei Li, Niuniu Ho
期刊:Journal for ImmunoTherapy of Cancer
影響因子 :10.900
引用產品:CL-0007 CL-0041 CL-0093 CL-0149 CL-0211 CL-0228 CL-0525 CM-0007 CM-0041 CM-0093 CM-0149 CM-0211 CM-0228 CM-0525
-
Cadmium promotes breast cancer cell proliferation, migration and invasion by inhibiting ACSS2/ATG5-mediated autophagy(2021/01/15)
作者:Yidan Liang, Huifeng Pi, Lingzhi Liao
期刊:Environmental Pollution
DOI:10.1016/j.envpol.2021.116504
影響因子 :8.900
-
Galangin attenuates doxorubicin-induced cardiotoxicity via activating nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation(2023/09/01)
作者:Guangyao Fang, Xiuchuan Li, Fengyuan Yang
期刊:PHYTOTHERAPY RESEARCH
DOI:10.1002/ptr.7991
影響因子 :7.200
-
N6-methyladenosine-mediated downregulation of miR-374c-5p promotes cadmium-induced cell proliferation and metastasis by targeting GRM3 in breast cancer cells( 2021/12/15)
作者:Yang Yue, Ping Deng, Heng Xiao
期刊: ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
DOI:10.1016/j.ecoenv.2021.113085
影響因子 :6.800
-
Rapamycin antagonizes cadmium-induced breast cancer cell proliferation and metastasis through directly modulating ACSS2(2021/08/16)
作者:Yidan Liang, Lai Yi, Ping Deng
期刊:Ecotoxicology And Environmental Safety
DOI:10.1016/j.ecoenv.2021.112626
影響因子 :6.800
-
A ddPCR platform based on a microfluidic chip with a dual-function flow-focusing structure for sample-to-result DNA quantification analysis(2023/12/28)
作者:xiaoliang zhang, Shun Wang, Jinxian Wang
期刊:LAB ON A CHIP
影響因子 :6.100
引用產品:CL-0228
-
MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT/mTOR pathway(2024/05/09)
作者:Pushuai Wen, Jing Li, Zihao Wen
期刊:BIOCHEMICAL PHARMACOLOGY
影響因子 :5.800
引用產品:CL-0228
-
OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer(2023/04/12)
作者:Kexin Wang, Qiuzi Li, Yufeng Fan
期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影響因子 :5.600
-
Extracellular vesicles released by hypoxia-induced tumor-associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery(2024/01/10)
作者:Shuang Tao, Jian Wang, Fang Li
期刊:FASEB JOURNAL
影響因子 :4.800
引用產品:CL-0228
-
ZNF746 promotes M2 macrophage polarisation and favours tumour progression in breast cancer via the Jagged1/Notch pathway(2023/09/18)
作者:Lu Liu, Wenyue Zhao, Xinyu Zheng
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2023.110892
影響因子 :4.800
引用產品:CL-0228
-
ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop(2023/06/16)
作者:Sijia Han, Xueying Jin, Tianyu Hu
期刊:CARCINOGENESIS
影響因子 :4.700
-
Baicalein promotes KDM4E to induce BICD1 and inhibit triple-negative breast cancer progression by blocking PAR1 signaling(2024/04/12)
作者:Yun Dong, Gaojian He, Kun Chen
期刊:MOLECULAR CARCINOGENESIS
DOI:10.1002/mc.23724
影響因子 :4.600
引用產品:CL-0228
-
LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β?catenin pathway(2023/02/10)
作者:Sijia Han, Xueying Jin, Tianyu Hu, Feng Chi
期刊:ONCOLOGY REPORTS
影響因子 :4.200
-
Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer(2022/01/13)
作者:Yingfang Shi, Shengxi Xu, Sen Li
期刊:MOLECULAR AND CELLULAR ENDOCRINOLOGY
影響因子 :4.100
-
The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer(2023/09/22)
作者:Yongshuo Yin, Xiao Guan, Genju Li
期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI:10.1016/j.taap.2023.116698
影響因子 :3.800
引用產品:CL-0149 CL-0228 CL-0525 PB180424 PM150110 PM150210 PM150312
-
The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway(2022/09/09)
作者:Jiao Yu, Kai Wang, Sanhu Yang
期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI:10.1016/j.taap.2022.116232
影響因子 :3.800
引用產品:CL-0041 CL-0114 CL-0149 CL-0228 CL-0324 CL-0525 PM150110 PM150312 PM150411
-
Mutant p53 and ELK1 co-drive FRA-1 Expression to induce metastasis in breast cancer(2023/11/16)
作者:Sike Hu, Manxue Wang, Ailing Ji
期刊:FEBS LETTERS
影響因子 :3.500
引用產品:CL-0228
-
Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells(2018/09/27)
作者:Zhijing Zhao, Junfeng Ma, Ying Mao
期刊:Medical Science Monitor
影響因子 :3.100
-
Synthesis of a biocompatible fluorinated multiblock copolymer surfactant for water-in-fluorocarbon droplets and its application in droplet digital polymerase chain reaction(2024/01/09)
作者:Ruijie Feng, Zeqin Li, Junyan Zhu
期刊:JOURNAL OF APPLIED POLYMER SCIENCE
影響因子 :3.000
引用產品:CL-0228
-
Identification of TFR2 as a novel ferroptosis?related gene that serves an important role in prognosis and progression of triple?negative breast cancer(2023/12/05)
作者:Yan Yang, Jie Du, Yunfei Huang
期刊:Oncology Letters
影響因子 :2.900
引用產品:CL-0228
-
Kuwanon C inhibits proliferation and induction of apoptosis via the intrinsic pathway in MDA-MB231 and T47D breast cancer cells(2024/05/31)
作者:Peng Qian, Gangxiang Yuan, Chao Yang
期刊:STEROIDS
DOI:10.1016/j.steroids.2024.109450
影響因子 :2.700
引用產品:CL-0228
-
Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway(2023/01/01)
作者:Jianchao He, Yuhui Bu, Xiaolong Li
期刊:BIOLOGICAL & PHARMACEUTICAL BULLETIN
影響因子 :2.000
引用產品:CL-0228
FAQs
Q:{{item.question}}
A:
產品資料
識別碼示意圖